ENP.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 31, 2025

Report Source: 2025 2nd Quarter Report

Entropy Neurodynamics Ltd

Entropy Neurodynamics Ltd. Stock Analysis ENP.AX

Australia Health Care Nano Cap Report:
Entropy Neurodynamics Ltd. is a clinical-stage biotechnology company, which engages in investing in biopharmaceutical drug development. The Company’s lead program, TRP-8803, is a proprietary formulation of IV infused psilocin (the active metabolite of psilocybin) with potential to alleviate numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe. The firm has completed a Phase 2a clinical trial for the treatment of binge eating disorder and for the treatment of fibromyalgia. Each of the studies is utilizing TRP-8802 (synthetic, oral psilocybin) to demonstrate clinical benefit in these indications.
Read More

Entropy Neurodynamics Ltd (ENP.AX) Chart

Key Statistics of Entropy Neurodynamics Ltd (ENP.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.04AUD0.04

Today's Open

AUD0.04

Volume

2.79M

P/E Ratio (TTM)

-

52 Week Range

AUD0.03AUD0.04

Market Cap

60.38M

Avg. Volume

-

Dividend Yield

-

Financial Metrics & Statements of Entropy Neurodynamics Ltd (ENP.AX)

FAQ's for Entropy Neurodynamics Ltd (ENP.AX)

  • According to Musaffa’s Shariah screening methodology, Entropy Neurodynamics Ltd (ENP.AX) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.